BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12720527)

  • 1. Substance misuse in patients with schizophrenia: a primary care guide.
    Lubman DI; Sundram S
    Med J Aust; 2003 May; 178(S9):S71-5. PubMed ID: 12720527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial interventions for people with both severe mental illness and substance misuse.
    Cleary M; Hunt G; Matheson S; Siegfried N; Walter G
    Cochrane Database Syst Rev; 2008 Jan; (1):CD001088. PubMed ID: 18253984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment programmes for people with both severe mental illness and substance misuse.
    Ley A; Jeffery DP; McLaren S; Siegfried N
    Cochrane Database Syst Rev; 2000; (4):CD001088. PubMed ID: 11034697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment programmes for people with both severe mental illness and substance misuse.
    Ley A; Jeffery DP; McLaren S; Siegfried N
    Cochrane Database Syst Rev; 2000; (2):CD001088. PubMed ID: 10796588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders.
    Crockford D; Addington D
    Can J Psychiatry; 2017 Sep; 62(9):624-634. PubMed ID: 28886671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does drug and alcohol misuse develop among people with psychotic illness? A literature review.
    Phillips P; Johnson S
    Soc Psychiatry Psychiatr Epidemiol; 2001 Jun; 36(6):269-76. PubMed ID: 11583456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial interventions for people with both severe mental illness and substance misuse.
    Hunt GE; Siegfried N; Morley K; Sitharthan T; Cleary M
    Cochrane Database Syst Rev; 2013 Oct; (10):CD001088. PubMed ID: 24092525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance abuse and first-episode schizophrenia-spectrum disorders. The Danish OPUS trial.
    Petersen L; Jeppesen P; Thorup A; Ohlenschlaeger J; Krarup G; Ostergård T; Jørgensen P; Nordentoft M
    Early Interv Psychiatry; 2007 Feb; 1(1):88-96. PubMed ID: 21352112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and Follow-Up Monitoring for Substance Use in Primary Care: An Exploration of Rural-Urban Variations.
    Chan YF; Lu SE; Howe B; Tieben H; Hoeft T; Unützer J
    J Gen Intern Med; 2016 Feb; 31(2):215-222. PubMed ID: 26269130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance misuse in patients with schizophrenia: epidemiology and management.
    Kavanagh DJ; McGrath J; Saunders JB; Dore G; Clark D
    Drugs; 2002; 62(5):743-55. PubMed ID: 11929329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ensuring integrated treatment for people with mental health and substance use problems.
    Hamilton I
    Nurs Times; 2010 Mar 23-29; 106(11):12-5. PubMed ID: 20391836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbid schizophrenia and substance abuse.
    Green AI; Brown ES
    J Clin Psychiatry; 2006 Sep; 67(9):e08. PubMed ID: 17081075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-occurring disorders of adolescents in primary care: closing the gaps.
    Huang LN; Freed R; Espiritu RC
    Adolesc Med Clin; 2006 Jun; 17(2):453-67. PubMed ID: 16814702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder.
    Miles H; Johnson S; Amponsah-Afuwape S; Finch E; Leese M; Thornicroft G
    Psychiatr Serv; 2003 Apr; 54(4):554-61. PubMed ID: 12663845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial approaches to dual diagnosis.
    Drake RE; Mueser KT
    Schizophr Bull; 2000; 26(1):105-18. PubMed ID: 10755672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance misuse and mental health.
    Peters Z
    Ment Health Today; 2010 Mar; ():21-3. PubMed ID: 20429106
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment and management of psychosis with coexisting substance misuse: summary of NICE guidance.
    Kendall T; Tyrer P; Whittington C; Taylor C;
    BMJ; 2011 Mar; 342():d1351. PubMed ID: 21430003
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of patients with schizophrenia and substance abuse disorders.
    Tsuang J; Fong TW
    Curr Pharm Des; 2004; 10(18):2249-61. PubMed ID: 15281900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.